Japanese Survey Finds Wide Diabetes Blood Device Reuse
This article was originally published in PharmAsia News
Executive Summary
A national survey disclosed 13,408 health institutions such as hospitals and clinics reused devices for drawing blood drops for diabetes tests. The Ministry of Health, Labor and Welfare conducted the survey after it was revealed in May that a clinic had used the same blood-drawing needle on many patients. In all but three cases, the part of the device that was reused was limited to the cap that encloses the needle. Only three institutions actually reused the needles themselves. The ministry said no health problems have been reported as a result of the practice. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.